ECOR ROCKET LONG SETBuy ECOR ON ROBINHOOD OR WEBULL
ENTRY 1 1.34
ENTRY 2 0.86
Tp.1 $3.00
Tp.2 $5.00
TP.3 $ 7.50
ECOR trade ideas
Test of the 3.00$ECOR Daily Timeframe / Not a big fan of the upper wick on the current daily candle but I would like to see price action test 3.00 again.
ECOR - Bullish In Force - Possible 20% Move Due.electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
SHORT INTEREST
1.47M 08/15/19
P/E Current
-1.87
P/E Ratio (with extraordinary items)
-1.20
Average Recommendation: OVERWEIGHT
Average Target Price: 10.50
$ECOR COULD BE A SIZABLE RALLY ON COST CUTTING UP 15%******UP PRE MARKET 15% BUT THIS COULD RUN A LOT HIGHER ON THE COMPANIES ANNOUNCEMENT OF RESTRUCTURING AND COST CUTTING, EXTREME RELIEF FOR INVESTORS WHOM WANTED A PRO ACTIVE APPROACH MUCH SOONER. *****
AVERAGE PRICE TARGET $20.50
AVERAGE RECOMMENDATION BUY
COMPANY PROFILE
electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache.
